Cyclerion Therapeutics CSO Andreas Busch's 2021 pay slips 3% to $783K

Cyclerion Therapeutics reports 2021 executive compensation

By ExecPay News

Published: April 26, 2022

Cyclerion Therapeutics reported fiscal year 2021 executive compensation information on April 26, 2022.
In 2021, three executives at Cyclerion Therapeutics received on average a compensation package of $518K, a 20% decrease compared to previous year.
Average pay of disclosed executives at Cyclerion Therapeutics
Andreas Busch, Chief Scientific Officer, received $783K in total, which decreased by 3% compared to 2020. 63% of Busch's compensation, or $492K, was in salary. Busch also received $136K in non-equity incentive plan, $113K in option awards, as well as $41K in other compensation.
Cheryl Gault, Chief Operating Officer, received a compensation package of $664K. 59% of the compensation package, or $395K, was in salary.
Peter M. Hecht, Chief Executive Officer, earned $108K in 2021, a 70% decrease compared to previous year.

Related executives

Peter Hecht

Cyclerion Therapeutics

Chief Executive Officer

Cheryl Gault

Cyclerion Therapeutics

Chief Operating Officer

Andreas Busch

Cyclerion Therapeutics

Chief Scientific Officer

You may also like

Source: SEC filing on April 26, 2022.